On May 22, 2023, the Center for Biologics Evaluation and Research (CBER) at the U.S. Food and Drug Administration (FDA)…
Read More →
As the scramble continues to reckon with the rapid advancement of generative artificial intelligence models like ChatGPT, Bard, DALL-E, and…
Read More →
The Republican heads of two significant House committees, Patrick McHenry of the House Financial Services Committee and Glenn Thompson of…
Read More →
On May 4, 2023, an Idaho federal judge ruled that the Federal Trade Commission (FTC) needs stronger assertions of consumer…
Read More →
As reflected in the posts on this blog over the last several years, scientific understanding of “mild traumatic brain injury”…
Read More →
A patient’s decision to take any prescription medication is a very personal one that requires the patient to weigh several…
Read More →
The Medicines and Healthcare products Regulatory Agency (MHRA) recently published long-awaited guidance confirming that there will be a delay in…
Read More →
On May 26, 2023, CMS published a proposed rule that would implement new policies under the Medicaid Drug Rebate Program…
Read More →
In our prior post in this two-part series on less commonly discussed technology commercialization options, we addressed how open-source software…
Read More →
Enacted in 2022, the laws in Colorado and Connecticut will now join California’s and Virginia’s laws in placing broad obligations…
Read More →